No recommendation
No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.
(Sharecast News) - Craneware reported a stronger-than-expected performance for the year ended 30 June on Wednesday, with adjusted EBITDA rising 12% to over $65m on the back of 9% revenue growth to $205.7m, ahead of consensus forecasts.
The AIM-traded healthcare software provider also posted a 7% increase in annual recurring revenue to approximately $184m, reflecting continued momentum in expanding its Trisus platform.
It said it saw net revenue retention rise sharply to 107%, up from 98% a year earlier, supported by expansion within its existing customer base.
Operating cash conversion remained strong, enabling Craneware to invest in product development, reduce bank debt from $35.4m to $27.7m, and boost cash reserves to $55.9m.
"We are pleased to see our growth rates accelerating and profitability exceed expectations, with this year's performance supporting a move to sustainable, double-digit growth," said CEO Keith Neilson.
"Our extensive data sets and the powerful insights we can provide via our Trisus platform give our customers the means they need to improve their operational and financial performance."
The company said demand remained strong for its 340B software offerings, with robust uptake of its 'Shelter' programme, which it said was driving recurring revenue and backlog growth into the 2026 financial year.
Craneware also highlighted progress on its AI-powered solutions in partnership with Microsoft, with further third-party partner offerings expected to go live on the Trisus platform in the first half of the new financial year.
The board said the accelerating trends in EBITDA, annual recurring revenue and customer retention gave it confidence in delivering faster revenue growth in 2026.
Full-year results would be published on 15 September.
At 1310 BST, shares in Craneware were up 12% at 2,520p.
Reporting by Josh White for Sharecast.com.
